Abstract: New 4,4′-(4,6-dimethoxy-1,3-phenylene)-bis-(N-substituted thiazol-2-amine) derivatives 5a-j were synthesized from 1,1′-(4,6-dimethoxy-1,3-phenylene)-bis(2-bromoethanone) 3 and substituted thioureas 4a-j under conventional and microwave irradiation conditions. All products were subjected to in vitro antibacterial and anti-TB evaluation. Some of the compounds exhibit good activities against Bacillus subtilis (+ve), Escherichia coli (−ve) strains and Mycobacterium tuberculosis H37Rv.
Introduction
Thiazoles are an important class of heterocyclic compounds that are potent anticancer [1] , antitumor [2] , antimalarial [3] , antimicrobial [4] and anti-inflammatory [5] agents. In particular, 2-aminothiazoles ( Figure 1 ) exhibit a wide range of activities [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . Many such compounds can be obtained using microwave assisted organic synthesis (MAOS) [15, 16] . In continuation of our previous efforts [18, 19] , in this work, we synthesized novel bis(N-substituted thiazol-2-amine) derivatives 5a-j by both conventional and microwave methods and investigated their in vitro antibacterial and anti-tuberculosis (TB) activities.
Results and discussion

Synthesis
Compounds 5a-j were prepared from 2,4-diacteylresorcinol (RDA) 1 which, in turn, was synthesized according to the literature procedure [20] , as shown in Scheme 1. First, the starting material 1 was subjected to methylation with methyl iodide in N,N-dimethylformamide in the presence of potassium carbonate. Then, the resultant product 2 was brominated by the reaction with bromine in acetic acid. Product 3 was treated with various substituted thioureas 4a-j in ethanol under microwave irradiation (MWI), which afforded the desired final compounds 5a-j in high yields (method B). The yields were lower for the same reactions conducted using the conventional heating method (method A).
Solvent screening under conventional and MWI conditions indicated that the use of ethanol as a solvent resulted in the highest yields for both methods. Reactions conducted in other solvents including dimethyl sulfoxide, N,N-dimethylformamide and tetrahydrofuran furnished products in much lower yields. The optimization studies are presented in Table S1 of the online supplementary material.
Biological activity
The in vitro antimicrobial activities of compounds 5a-j were investigated against four pathogenic microorganisms Staphylococcus aureus (MTCC 737), Escherichia coli (MTCC 443), Bacillus subtilis (MTCC 441) and Pseudomonas aeruginosa (MTCC 741) at the concentration of 100 μg/mL using streptomycin as a standard drug in the cup-plate agar diffusion method. As shown in Figure 2 and Table S2 , compounds 5d, 5f, 5h (inhibition zone >5 mm) show greater growth inhibition against B. subtilis then the reference drug streptomycin (5 mm). Activity of 5g against Gram-negative bacteria E. coli equals the activity of the reference drug.
The investigation of in vitro anti-TB activity revealed that compounds 5d, 5f and 5h are strongly antitubercular, and 5h is much more active than the standard drug rifampicin ( Figure 3) . The results are also tabulated in Table S3 .
Conclusions
Symmetrical bis(N-substituted thiazol-2-amine) derivatives 5a-j were synthesized. Some compounds show excellent in vitro anti-TB and antibacterial activity.
Experimental
Infra red (IR) spectra were recorded on a Shimadzu FTIR-8400S spectrometer. 1 H nuclear magnetic resonance (NMR) spectra (300 MHz) and 13 C NMR spectra (75 MHz) were acquired on a Bruker Avance 300 spectrometer in DMSO-d 6 using tetramethylsilane (TMS) as an internal standard. Mass spectra were recorded on a Shimadzu LCMS2020 spectrometer. Elemental analyses were performed on a Carlo Erba EA1106 elemental analyzer. Melting points were determined in open capillary tubes on a Stuart SMP3 melting point apparatus and are uncorrected. Microwave reactions were carried out in an Anton Paar Monowave 300 microwave (2.45 GHz) with a maximum delivered power of 850 W in 10 W increments (pulsed irradiation). A thin layer chromatography (TLC) analysis was performed on precoated Merck 60F 254 silica gel plates with visualization by exposing to iodine vapor and under ultra violet (UV) light. Substituted thioureas 4a-j were synthesized as previously described [21] [22] [23] . 
1,1′-(4,6-Dimethoxy-1,3-phenylene)-bis(2-bromoethanone) (3)
A solution of 2 (1.0 g, 0.0045 mol) in acetic acid (10 mL) was heated to 50°C and treated with bromine (0.46 mL, 0.009 mol) in acetic acid (5 mL). The mixture was stirred at 50 o C for 15 min, quenched with crushed ice and extracted with dichloromethane (2 × 10 mL).
The combined organic layers were dried over anhydrous sodium sulfate, concentrated and the residue was subjected to silica gel (60-120 mesh) column chromatography eluting with 10%-20% EtOAc/ hexane: white solid; yield 71%; mp 182-185°C (dec); IR: 3016 (Ar-CH), 2954 (C-H), 1672 (C = O), 1558 (C = C) cm General procedure for the preparation of 4,4′-(4,6-dimethoxy-1,3-phenylene)-bis(N-substituted thiazol-2-amine)s 5a-j Conventional heating method (A) To a stirred solution of 3 (0.38 g, 0.001 mol) in ethanol (10 mL), was added substituted thiourea 4a-j (0.002 mol) in ethanol (10 mL) and the mixture was heated under refluxed for a period of time indicated below. After completion of the reaction, the mixture was concentrated under reduced pressure and the residue was subjected to column chromatography on basic alumina eluting with 30%-40% EtOAc/hexane.
Microwave irradiation method (B)
A mixture of 3 (0.38 g, 0.001 mol), substituted thiourea 4a-j (0.002 mol) and ethanol (10 mL) was placed in a microwave tube and subjected to microwave irradiation at 180 W for 8-20 min. Workup and purification were conducted as described above. -(4,6-Dimethoxy-1,3-phenylene)-bis(N-(3-(trifluoromethyl 
4,4′
Antibacterial activity assay
Gram-negative strains (P. aeruginosa and E. coli) and Gram-positive strains (B. subtilis and S. aureus) were obtained from Microbial Type Culture Collection MTCC. The biological activities of the compounds were assayed using the standard disc diffusion method [25] for 100 μg/mL solutions in DMSO. Inhibition zones were measured and compared with the standard positive control (streptomycin) at 100 μg/mL.
Antimycobacterial activity assay
Mycobacterium tuberculosis H37Rv (ATCC 27294) and Middlebrook 7H9 medium were used. The activity was assayed by the turbidometry method [26] using rifampicin as standard.
